{
    "clinical_study": {
        "@rank": "152856", 
        "acronym": "Gadovit", 
        "arm_group": [
            {
                "arm_group_label": "Gadobutrol", 
                "arm_group_type": "Experimental", 
                "description": "first session gadobutrol second session gadobenate dimeglumin"
            }, 
            {
                "arm_group_label": "Demeglumin", 
                "arm_group_type": "Experimental", 
                "description": "first session gadobenate dimeglumin second session gadobutrol"
            }
        ], 
        "brief_summary": {
            "textblock": "This study aims at evaluating the diagnostic efficacy of Gadobutrol versus Gadobenate\n      dimeglumine at similar dose of 0.1mmol/kg for assessment of myocardial infarction by delayed\n      enhancement cardiac Magnetic Resonance Imaging"
        }, 
        "brief_title": "Comparison of Gadobutrol and Gadobenate Dimeglumin for Delayed Enhancement Cardiac MRI", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Subacute/Chronic Myocardial Infarction", 
        "condition_browse": {
            "mesh_term": [
                "Infarction", 
                "Myocardial Infarction"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosis of myocardial infarction\n\n          -  Age \u2265 18 years and \u2264 80 years\n\n          -  Informed consent\n\n          -  Male patients as well as female patients using contraceptives\n\n        Exclusion Criteria:\n\n          -  Patients with a heart pacemaker, with magnetic material or other magnetic implants.\n\n          -  Renal failure (GFR <30ml/min)\n\n          -  Patients with known allergy to a Gadolinium-containing contrast agent\n\n          -  Drugs or alcohol addiction, dementia"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 30, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01655290", 
            "org_study_id": "GAD-1140-WIL-0020-I"
        }, 
        "intervention": {
            "arm_group_label": [
                "Gadobutrol", 
                "Demeglumin"
            ], 
            "description": "Other (Diagnostic)", 
            "intervention_name": "Gadovist\u00ae (Gadobutrol), Multihance\u00ae (Gadobenate dimeglumin)", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 15, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Munic", 
                    "country": "Germany", 
                    "state": "Bavaria", 
                    "zip": "81675"
                }, 
                "name": "Institut f\u00fcr Radiologie - Klinikum Rechts der Isar"
            }
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "2", 
        "official_title": "Intraindividual Comparison of the Diagnostic Accuracy Using Gadobutrol (Gadovist\u00ae) Versus Gadobenat Dimeglumin (Multihance\u00ae) for Delayed Enhancement MRI of Myocardial Infarction.", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Germany: District Government of Upper Bavaria", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "May 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Efficacy (contrast-to-noise ratio)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01655290"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Technische Universit\u00e4t M\u00fcnchen", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Technische Universit\u00e4t M\u00fcnchen", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}